Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
暂无分享,去创建一个
[1] H. Boehmer,et al. Mechanisms of suppression by suppressor T cells , 2005, Nature Immunology.
[2] A. Rudensky,et al. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.
[3] Shimon Sakaguchi,et al. Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization , 2005, The Journal of experimental medicine.
[4] H. Waldmann,et al. Regulatory T cells in transplantation tolerance. , 2005, Current topics in microbiology and immunology.
[5] S. Sakaguchi,et al. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. , 2004, International immunology.
[6] M. Neurath,et al. Cutting Edge: TGF-β Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells1 , 2004, The Journal of Immunology.
[7] J. Bluestone,et al. Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function , 2004 .
[8] R. Medzhitov,et al. Toll-dependent control mechanisms of CD4 T cell activation. , 2004, Immunity.
[9] T. Nomura,et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. , 2004, International immunology.
[10] V. Kuchroo,et al. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[11] Ethan M. Shevach,et al. Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells , 2004, The Journal of Immunology.
[12] G. Szot,et al. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. , 2004, The Journal of clinical investigation.
[13] Clare Baecher-Allan,et al. Suppressor T Cells in Human Diseases , 2004, The Journal of experimental medicine.
[14] A. Rudensky,et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. , 2004, Immunity.
[15] R. Schreiber,et al. The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.
[16] S. Sakaguchi,et al. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. , 2004, International immunology.
[17] B. Levine,et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. , 2004, Blood.
[18] Linrong Lu,et al. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Andreesen,et al. Large scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells , 2004, Cancer Cell International.
[20] I. Ishikawa,et al. Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells1 , 2004, The Journal of Immunology.
[21] R. Steinman,et al. CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.
[22] Jeffrey A. Bluestone,et al. In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.
[23] Ethan M. Shevach,et al. Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function , 2004, The Journal of Immunology.
[24] W. Faubion,et al. Cutting Edge: The Natural Ligand for Glucocorticoid-Induced TNF Receptor-Related Protein Abrogates Regulatory T Cell Suppression 1 , 2004, The Journal of Immunology.
[25] H. Waldmann,et al. Regulatory T cells and organ transplantation. , 2004, Seminars in immunology.
[26] D. Munn,et al. Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells1 , 2004, The Journal of Immunology.
[27] R. Flavell,et al. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Sakaguchi. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.
[29] D. Sansom,et al. CD86 and CD80 Differentially Modulate the Suppressive Function of Human Regulatory T Cells1 , 2004, The Journal of Immunology.
[30] A. G. Betz,et al. Regulatory T cells mediate maternal tolerance to the fetus , 2004, Nature Immunology.
[31] C. Yee,et al. Autoreactive T Cells in Healthy Individuals , 2004 .
[32] 金丸 史子. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25[+] regulatory CD4[+] T cells , 2004 .
[33] J. Bluestone,et al. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. , 2004, European journal of immunology.
[34] T. Utsugi,et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. , 2003, Immunity.
[35] H. Waldmann,et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] U. Grohmann,et al. Modulation of tryptophan catabolism by regulatory T cells , 2003, Nature Immunology.
[37] J. Bluestone,et al. Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells 1 , 2003, The Journal of Immunology.
[38] D. Klatzmann,et al. Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State , 2003, The Journal of experimental medicine.
[39] H. Ikeda,et al. CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Steinman,et al. Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells , 2003, The Journal of experimental medicine.
[41] Anna Chodos,et al. Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo , 2003, The Journal of experimental medicine.
[42] L. Klein,et al. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[43] H. Ochs,et al. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis , 2003, Current opinion in rheumatology.
[44] Thomas A. Davis,et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] Luc J. Smink,et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease , 2003, Nature.
[46] F. Ramsdell,et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.
[47] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[48] I. Caramalho,et al. Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide , 2003, The Journal of experimental medicine.
[49] Ruslan Medzhitov,et al. Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.
[50] T. Nomura,et al. Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .
[51] A. Rudensky,et al. Foxp 3 programs the development and function of CD 4 + CD 25 + regulatory T cells , 2003 .
[52] A. Freitas,et al. Homeostasis of Peripheral CD4+ T Cells: IL-2Rα and IL-2 Shape a Population of Regulatory Cells That Controls CD4+ T Cell Numbers1 , 2002, The Journal of Immunology.
[53] T. Elliott,et al. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens , 2002, European journal of immunology.
[54] P. Blair,et al. Inhibition of human T cell proliferation by CTLA‐4 utilizes CD80 and requires CD25+ regulatory T cells , 2002, European journal of immunology.
[55] R. Badolato,et al. X‐chromosome inactivation analysis in a female carrier of FOXP3 mutation , 2002, Clinical and experimental immunology.
[56] J. Bach,et al. The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.
[57] J. Lafaille,et al. Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function , 2002, The Journal of experimental medicine.
[58] E. Zackai,et al. CD4+ CD25+ T-Cell Production in Healthy Humans and in Patients with Thymic Hypoplasia , 2002, Clinical and Vaccine Immunology.
[59] T. Malek,et al. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. , 2002, Immunity.
[60] Andrea Iaboni,et al. The interaction properties of costimulatory molecules revisited. , 2002, Immunity.
[61] P. Pandolfi,et al. Role of GITR in activation response of T lymphocytes. , 2002, Blood.
[62] Akemi Sakamoto,et al. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[63] Ethan M. Shevach,et al. Cutting Edge: Depletion of CD4+CD25+ Regulatory T Cells Is Necessary, But Not Sufficient, for Induction of Organ-Specific Autoimmune Disease , 2002, The Journal of Immunology.
[64] M. Byrne,et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.
[65] J. Shimizu,et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.
[66] T. Schumacher,et al. Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.
[67] W. Strober,et al. Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β , 2001, The Journal of experimental medicine.
[68] F. Powrie,et al. Control of intestinal inflammation by regulatory T cells. , 2001, Microbes and infection.
[69] F. Powrie,et al. Regulatory T cells in the control of immune pathology , 2001, Nature Immunology.
[70] I. Caramalho,et al. Regulatory T cells: the physiology of autoreactivity in dominant tolerance and “quality control” of immune responses , 2001, Immunological reviews.
[71] T. Hünig,et al. Control of T cell hyperactivation in IL‐2‐deficient mice by CD4+CD25– and CD4+CD25+ T cells: evidence for two distinct regulatory mechanisms , 2001, European journal of immunology.
[72] H. Kikutani,et al. Increased T Cell Autoreactivity in the Absence of CD40-CD40 Ligand Interactions: A Role of CD40 in Regulatory T Cell Development1 , 2001, The Journal of Immunology.
[73] H. Ochs,et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.
[74] J. Casanova,et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.
[75] D. Galas,et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.
[76] A. Bowcock,et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. , 2000, The Journal of clinical investigation.
[77] D. Mason,et al. CD25 Is a Marker for CD4+ Thymocytes That Prevent Autoimmune Diabetes in Rats, But Peripheral T Cells with This Function Are Found in Both CD25+ and CD25− Subpopulations1 , 2000, The Journal of Immunology.
[78] T. Mak,et al. Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.
[79] Fiona Powrie,et al. Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.
[80] J. Todd,et al. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene? , 2000, Cytokine.
[81] J. Bluestone,et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.
[82] E. Shevach. Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.
[83] J. Shimizu,et al. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. , 1999, Journal of immunology.
[84] T. Mak,et al. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. , 1999, Journal of immunology.
[85] T. Fujita,et al. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. , 1999, Cancer research.
[86] F. Otsuka,et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. , 1999, Journal of immunology.
[87] J. Seidman,et al. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2 , 1999, Nature Genetics.
[88] 鬼塚 正三郎. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody , 1999 .
[89] M. Toda,et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. , 1998, International immunology.
[90] Ethan M. Shevach,et al. CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.
[91] E. Shevach,et al. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. , 1998, Journal of immunology.
[92] B. Nelson,et al. Biology of the interleukin-2 receptor. , 1998, Advances in immunology.
[93] Hervé Groux,et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.
[94] I. Autenrieth,et al. Interleukin-2 is indispensable for development of immunological self-tolerance. , 1996, Clinical immunology and immunopathology.
[95] S. Sakaguchi,et al. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation , 1996, The Journal of experimental medicine.
[96] Toshitada Takahashi,et al. Administration of anti‐interleukin‐2 receptor α antibody in vivo induces localized autoimmune disease , 1996, European journal of immunology.
[97] K. Sugamura,et al. Lack of intermediate‐affinity interleukin‐2 receptor in mice leads to dependence on interleukin‐2 receptor α, β and γ chain expression for T cell growth , 1996 .
[98] Kendall A. Smith,et al. Interleukin‐2 Deficient Mice: A New Model to Study Autoimmunity and Self‐Tolerance , 1995, Immunological reviews.
[99] T. Hünig,et al. Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene , 1995, The Journal of experimental medicine.
[100] H. Griesser,et al. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.
[101] J. Bluestone,et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.
[102] F. Alt,et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.
[103] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[104] H. Griesser,et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.
[105] H. Weiner,et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. , 1994, Science.
[106] P. Bruggen,et al. Tumor antigens recognized by T lymphocytes. , 1994, Annual review of immunology.
[107] D. Mason,et al. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset [published erratum appears in J Exp Med 1991 Apr 1;173(4):1037] , 1990, The Journal of experimental medicine.
[108] D. Greiner,et al. Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[109] M. Adinolfi. of Immune Responses , 1989 .
[110] P Rubinstein,et al. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. , 1985, Reviews of infectious diseases.
[111] S. Sakaguchi,et al. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease , 1985, The Journal of experimental medicine.
[112] D. H. Besterfield. Quality control , 1979 .